In Era Of Public Rage Over Drug Prices, Cory Booker Is Haunted By His Past Relationship With ‘Big Pharma’

This post was originally published on this site

As Sen. Cory Booker (D-N.J.) eyes the 2020 White House race, he’s scrambling to mitigate any damage that may have been done by his decision to accept campaign donations from pharmaceutical companies. As public outrage boils over about high drug prices, most presidential contenders, such as Sen. Amy Klobuchar (D-Minn.), are trying to get in front of the issue by offering plans they believe will demonstrate a hard stance against Big Pharma.